• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Therapeutic study on melanoma-killing activity of plasma-stimulated medium

Research Project

Project/Area Number 15K09792
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeMulti-year Fund
Section一般
Research Field Dermatology
Research InstitutionNihon University

Principal Investigator

OCHIAI Toyoko  日本大学, 医学部, 教授 (40133425)

Co-Investigator(Kenkyū-buntansha) 鈴木 良弘  日本大学, 医学部, 研究員 (80206549)
Project Period (FY) 2015-04-01 – 2018-03-31
Project Status Completed (Fiscal Year 2017)
Budget Amount *help
¥4,810,000 (Direct Cost: ¥3,700,000、Indirect Cost: ¥1,110,000)
Fiscal Year 2017: ¥1,300,000 (Direct Cost: ¥1,000,000、Indirect Cost: ¥300,000)
Fiscal Year 2016: ¥1,300,000 (Direct Cost: ¥1,000,000、Indirect Cost: ¥300,000)
Fiscal Year 2015: ¥2,210,000 (Direct Cost: ¥1,700,000、Indirect Cost: ¥510,000)
Keywords低温大気圧プラズマ / メラノーマ / 腫瘍選択性 / ミトコンドリア / 活性酸素 / 酸化ストレス / アポトーシス / AGP / 抗がん作用 / ミトコンドリアダイナミクス / Drp-1 / TRAIL
Outline of Final Research Achievements

Plasma-stimulated medium (PSM) has emerged as a cold atmospheric plasma-based anticancer tool because it exhibits cytotoxicity against malignant cells, but not toward normal cells. However, the mechanisms of the anticancer effect and those underlying the tumor-selectivity remain unclear. We found that PSM induced mitochondrial network aberration in human malignant melanoma cells, but not in melanocytes. PSM had reactive oxygen species (ROS), which in turn resulted in the generation of superoxide within the mitochondria. The oxidative stress caused excessive mitochondrial fragmentation, swelling, and clustering, and a caspase-independent cell killing. The heavier mitochondrial network aberration in melanoma cells resulted from their higher sensitivity to mitochondrial ROS accumulation, plasma membrane depolarization, and calcium dysregulation. Our findings indicate the importance of mitochondrial network remodeling as a powerful target for tumor-selective melanoma treatment by PSM.

Report

(4 results)
  • 2017 Annual Research Report   Final Research Report ( PDF )
  • 2016 Research-status Report
  • 2015 Research-status Report
  • Research Products

    (6 results)

All 2018 2017 2016 2015

All Journal Article (4 results) (of which Peer Reviewed: 4 results,  Open Access: 3 results,  Acknowledgement Compliant: 1 results) Presentation (2 results) (of which Int'l Joint Research: 1 results,  Invited: 1 results)

  • [Journal Article] Cold plasma-stimulated medium (PSM), but not TRAIL, trigger autophagic cell death: a therapeutic advantage of PSM over TRAIL.2018

    • Author(s)
      Ito T, Ando T, Suzuki-Karasaki M, Tokunaga T, Yoshida Y, Ochiai T, Tokuhashi Y Suzuki-Karasaki Y.
    • Journal Title

      Int J Oncol

      Volume: 印刷中

    • Related Report
      2017 Annual Research Report
    • Peer Reviewed / Open Access
  • [Journal Article] Plasma-stimulated medium kills TRAIL-resistant human malignant cells by promoting caspase-independent cell death via membrane potential and calcium dynamics modulation.2018

    • Author(s)
      Tokunaga, Ando T, Suzuki-Karasaki M, Ito T, Onoe-Takahashi A, Ochai T, Soma M, Suzuki-Karasaki Y.
    • Journal Title

      Int J Oncol

      Volume: 52(3) Pages: 697-708

    • DOI

      10.3892/ijo.2018.4251

    • Related Report
      2017 Annual Research Report
    • Peer Reviewed / Open Access
  • [Journal Article] Distinct effects of TRAIL on the mitochondria network in human cancer cells and normal cells: role of plasma membrane depolarization.2015

    • Author(s)
      Yoshihiro Suzuki-Karasaki et al.
    • Journal Title

      Oncotarget

      Volume: 6 Issue: 15 Pages: 21572-21588

    • DOI

      10.18632/oncotarget.7889

    • Related Report
      2016 Research-status Report
    • Peer Reviewed / Open Access / Acknowledgement Compliant
  • [Journal Article] Distinct effects of TRAIL on the mitochondrial network in human cancer cells and normal cells :role of plasma membrane depolarization2015

    • Author(s)
      Yoshihiro Suzuki-Karasaki , Toyoko Ochiai et al.
    • Journal Title

      Oncotarget

      Volume: 6 Pages: 21572-21588

    • Related Report
      2015 Research-status Report
    • Peer Reviewed
  • [Presentation] Plasma-stimulated medium (PSM)のアポト-シス抵抗性悪性腫瘍に対する抗腫瘍作用メカニズム2017

    • Author(s)
      徳永智彦、小野江明日香、相馬正義、落合豊子、鈴木良弘
    • Organizer
      第33回日本皮膚悪性腫瘍学会学術大会
    • Related Report
      2017 Annual Research Report
  • [Presentation] Tumor-targeting killing of multidrug-resistant aggressive cancer cells by plasma-activated media via mitochondrial and endoplasmic reticulum damage.2016

    • Author(s)
      Yoshihiro Suzuki-Karasaki
    • Organizer
      21th World Congress on Advances in Oncology & 19th International Symposium on Molecular Medicine.
    • Place of Presentation
      Greece, Athens, Metropolitan Hotel
    • Year and Date
      2016-10-06
    • Related Report
      2016 Research-status Report
    • Int'l Joint Research / Invited

URL: 

Published: 2015-04-16   Modified: 2019-03-29  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi